Enoticumab Antibody
Enoticumab (REGN421) is a fully human IgG1 monoclonal antibody targeting human Dll4 to inhibit Notch signaling and cancer cell growth. It is used in oncology research for investigating angiogenesis and tumor progression in both in vitro and in vivo experimental models.
Product Specifications
Product Name Alternative
DLL4, Gammasecretase, SAR153192, SAR-153192, REGN421, REGN-421
Target
Gamma-secretase
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Neuroscience, Protein Biochemistry, Stem Cell & Developmental Biology
Concentration
6.19 mg/mL
Purity
98.20% (May vary between batches)
Molecular Weight
146.22 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1201226 Inquire
Recombinant Danio rerio Tubulin polyglutamylase ttll6 (ttll6), partial
Sign In for Pricing
View Details 
SDA72200-01 50 mg
2-Methyl-5-nitro-1- (propan-2-yl) -1H-1,3-benzodiazole
Sign In for Pricing
View Details SDA72200-02 0.5 g
2-Methyl-5-nitro-1- (propan-2-yl) -1H-1,3-benzodiazole
Sign In for Pricing
View Details